Catalyst Calendar

Thu, Oct 1, 2026

2 updates

9:00 AM

Novocure’s Optune Pax® Receives Approval in Japan for the Treatment of Unresectable Locally Advanced Pancreatic Cancer

BAAR, Switzerland --(BUSINESS WIRE)--Oct. 1, 2026-- Novocure (Nasdaq: NVCR) announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Optune Pax ® for the treatment of adult patients diagnosed with unresectable locally advanced pancreatic cancer, concomitant with

novocure.com

NVCR

7:00 AM

Novocure to Report Third Quarter 2026 Financial Results

BAAR, Switzerland --(BUSINESS WIRE)--Oct. 1, 2026-- Novocure (Nasdaq: NVCR) will report financial results for the third quarter 2026 on October 29, 2026, before the U.S. financial markets open. Novocure management will host a conference call and webcast at 8:00 a.m.

novocure.com

Wed, Sep 2, 2026

1 updates

NVCR

7:00 AM

Novocure Announces Upcoming Investor Events

BAAR, Switzerland --(BUSINESS WIRE)--Sep. 2, 2026-- Novocure (NASDAQ: NVCR) announced today that management will participate in two upcoming investor events. Wells Fargo 21st Annual Healthcare Conference, September 9, 2026: Frank Leonard, Chief Executive Officer, will take part in a fireside chat

novocure.com